已发表论文

血清可溶性清道夫受体 A 水平与动脉瘤性蛛网膜下腔出血后迟发性脑缺血和不良临床结果相关:一项前瞻性观察研究

 

Authors Jiang F, Chen Z, Hu J, Liu Q

Received 25 August 2022

Accepted for publication 20 October 2022

Published 2 November 2022 Volume 2022:18 Pages 2529—2541

DOI https://doi.org/10.2147/NDT.S387487

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Taro Kishi

Objective: Scavenger receptor A (SRA), a pattern recognition molecule, is implicated in immune response after acute brain injury. We strived to identify serum soluble SRA (sSRA) as a potential biomarker of prognosis after aneurysmal subarachnoid hemorrhage (aSAH).
Methods: In this prospective observational study, we quantified serum sSRA levels of 131 aSAH patients and 131 healthy controls. A poor outcome was defined as extended Glasgow outcome scale (GOSE) scores of 1– 4 at 90 days after injury. Relations of serum sSRA levels to severity, delayed cerebral ischemia (DCI) and poor outcome were assessed using multivariate analysis. Predictive efficiency was determined via area under receiver operating characteristic curve (AUC).
Results: Serum sSRA levels were markedly higher in aSAH patients than in controls (median, 2.9 ng/mL versus 1.0 ng/mL; P < 0.001). Serum sSRA levels were independently correlated with Hunt-Hess scores (beta, 0.569; 95% confidence interval (CI), 0.244– 0.894; P = 0.001), modified Fisher scores (beta, 0.664; 95% CI, 0.254– 1.074; P = 0.002) and 90-day GOSE scores (beta, − 0.275; 95% CI, − 0.440– 0.110; P = 0.005). Serum sSRA levels independently predicted DCI (odds ratio, 1.305; 95% CI, 1.012– 1.687; P = 0.040) and a poor outcome (odds ratio, 2.444; 95% CI, 1.264– 4.726; P = 0.008), as well as showed significant accuracy for the discrimination of DCI (AUC, 0.753; 95% CI, 0.649– 0.857; P < 0.001) and a poor outcome (AUC, 0.800; 95% CI, 0.721– 0.880; P < 0.001). Its combination with Hunt-Hess scores and modified Fisher scores displayed significantly improved AUCs for predicting DCI and poor outcome, as compared to any of them (all P < 0.05).
Conclusion: There is a significant elevation of serum sSRA levels after aSAH, which in close correlation with illness severity, are independently associated with DCI and poor clinical outcome after aSAH. Hypothetically, SRA may regulate immune response in acute brain injury after aSAH and serum sSRA is presumed to be a potential prognostic biomarker of aSAH.
Keywords: aneurysm, subarachnoid hemorrhage, scavenger receptor A, delayed cerebral ischemia, prognosis, severity, biomarkers, mechanism